First Light Acquisition Group LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 06:05 am Sale |
2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
First Light Acquisition Group LLC | 34,369 11.000% |
-223,212![]() (-86.66%) |
Filing |
2023-02-10 5:23 pm Sale |
2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
First Light Acquisition Group LLC | 257,580 38.400% |
-202,995![]() (-44.07%) |
Filing |
2022-02-11 06:17 am Purchase |
2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
First Light Acquisition Group LLC | 460,575 16.000% |
460,575![]() (New Position) |
Filing |